Status:
COMPLETED
Nexavar Post-marketing Surveillance for Hepatocellular Carcinoma in Japan
Lead Sponsor:
Bayer
Conditions:
Carcinoma, Hepatocellular
Eligibility:
All Genders
Brief Summary
This study is a regulatory post-marketing surveillance in Japan, and it is a local prospective and observational study of patients who have received Nexavar for unresectable hepatocellular carcinoma (...
Eligibility Criteria
Inclusion
- Patients who received Nexavar for unresectable hepatocellular carcinoma
Exclusion
- Patients who are contraindicated based on the product label
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
1637 Patients enrolled
Trial Details
Trial ID
NCT01411436
Start Date
May 1 2009
End Date
February 1 2015
Last Update
March 4 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Japan